Global Neurorehabilitation and Assistive Device 麻豆原创 Research Report 2024

Publication ID:

PB508242368

Publication Date:

August 14, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Neurorehabilitation and assistive devices refer to tools, equipment, and technologies designed to aid individuals who have experienced neurological injuries or disorders in regaining or improving their physical and cognitive functions. These devices are an integral part of neurorehabilitation programs and are aimed at enhancing the quality of life and independence of individuals with neurological impairments.
The global Neurorehabilitation and Assistive Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The integration of cutting-edge technologies such as robotics, virtual reality (VR), augmented reality (AR), and artificial intelligence (AI) has significantly enhanced the effectiveness of neurorehabilitation and assistive devices. These technologies provide personalized and interactive rehabilitation experiences.
This report aims to provide a comprehensive presentation of the global market for Neurorehabilitation and Assistive Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurorehabilitation and Assistive Device.
Report Scope
The Neurorehabilitation and Assistive Device market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurorehabilitation and Assistive Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurorehabilitation and Assistive Device companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma
Neuronetics
Magstim
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical
Segment by Type
Brain Neurorehabilitation and Assistive Device
Arms Neurorehabilitation and Assistive Device
Legs Neurorehabilitation and Assistive Device
Other
Segment by Application
Hospital
Rehabilitation Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurorehabilitation and Assistive Device companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Neurorehabilitation and Assistive Device 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Brain Neurorehabilitation and Assistive Device
1.2.3 Arms Neurorehabilitation and Assistive Device
1.2.4 Legs Neurorehabilitation and Assistive Device
1.2.5 Other
1.3 麻豆原创 by Application
1.3.1 Global Neurorehabilitation and Assistive Device 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Rehabilitation Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurorehabilitation and Assistive Device 麻豆原创 Perspective (2019-2030)
2.2 Neurorehabilitation and Assistive Device Growth Trends by Region
2.2.1 Global Neurorehabilitation and Assistive Device 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neurorehabilitation and Assistive Device Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Neurorehabilitation and Assistive Device Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Neurorehabilitation and Assistive Device 麻豆原创 Dynamics
2.3.1 Neurorehabilitation and Assistive Device Industry Trends
2.3.2 Neurorehabilitation and Assistive Device 麻豆原创 Drivers
2.3.3 Neurorehabilitation and Assistive Device 麻豆原创 Challenges
2.3.4 Neurorehabilitation and Assistive Device 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurorehabilitation and Assistive Device Players by Revenue
3.1.1 Global Top Neurorehabilitation and Assistive Device Players by Revenue (2019-2024)
3.1.2 Global Neurorehabilitation and Assistive Device Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Neurorehabilitation and Assistive Device 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurorehabilitation and Assistive Device Revenue
3.4 Global Neurorehabilitation and Assistive Device 麻豆原创 Concentration Ratio
3.4.1 Global Neurorehabilitation and Assistive Device 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurorehabilitation and Assistive Device Revenue in 2023
3.5 Neurorehabilitation and Assistive Device Key Players Head office and Area Served
3.6 Key Players Neurorehabilitation and Assistive Device Product Solution and Service
3.7 Date of Enter into Neurorehabilitation and Assistive Device 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurorehabilitation and Assistive Device Breakdown Data by Type
4.1 Global Neurorehabilitation and Assistive Device Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Neurorehabilitation and Assistive Device Forecasted 麻豆原创 Size by Type (2025-2030)
5 Neurorehabilitation and Assistive Device Breakdown Data by Application
5.1 Global Neurorehabilitation and Assistive Device Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Neurorehabilitation and Assistive Device Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Neurorehabilitation and Assistive Device 麻豆原创 Size (2019-2030)
6.2 North America Neurorehabilitation and Assistive Device 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neurorehabilitation and Assistive Device 麻豆原创 Size by Country (2019-2024)
6.4 North America Neurorehabilitation and Assistive Device 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurorehabilitation and Assistive Device 麻豆原创 Size (2019-2030)
7.2 Europe Neurorehabilitation and Assistive Device 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neurorehabilitation and Assistive Device 麻豆原创 Size by Country (2019-2024)
7.4 Europe Neurorehabilitation and Assistive Device 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurorehabilitation and Assistive Device 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Neurorehabilitation and Assistive Device 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neurorehabilitation and Assistive Device 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Neurorehabilitation and Assistive Device 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurorehabilitation and Assistive Device 麻豆原创 Size (2019-2030)
9.2 Latin America Neurorehabilitation and Assistive Device 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neurorehabilitation and Assistive Device 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Neurorehabilitation and Assistive Device 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurorehabilitation and Assistive Device 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Neurorehabilitation and Assistive Device 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neurorehabilitation and Assistive Device 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Neurorehabilitation and Assistive Device 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Neurorehabilitation and Assistive Device Introduction
11.1.4 Medtronic Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Neurorehabilitation and Assistive Device Introduction
11.2.4 Abbott Laboratories Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Detail
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Neurorehabilitation and Assistive Device Introduction
11.3.4 Boston Scientific Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.3.5 Boston Scientific Recent Development
11.4 Bioness
11.4.1 Bioness Company Detail
11.4.2 Bioness Business Overview
11.4.3 Bioness Neurorehabilitation and Assistive Device Introduction
11.4.4 Bioness Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.4.5 Bioness Recent Development
11.5 Hocoma
11.5.1 Hocoma Company Detail
11.5.2 Hocoma Business Overview
11.5.3 Hocoma Neurorehabilitation and Assistive Device Introduction
11.5.4 Hocoma Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.5.5 Hocoma Recent Development
11.6 Neuronetics
11.6.1 Neuronetics Company Detail
11.6.2 Neuronetics Business Overview
11.6.3 Neuronetics Neurorehabilitation and Assistive Device Introduction
11.6.4 Neuronetics Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.6.5 Neuronetics Recent Development
11.7 Magstim
11.7.1 Magstim Company Detail
11.7.2 Magstim Business Overview
11.7.3 Magstim Neurorehabilitation and Assistive Device Introduction
11.7.4 Magstim Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.7.5 Magstim Recent Development
11.8 Ekso Bionics
11.8.1 Ekso Bionics Company Detail
11.8.2 Ekso Bionics Business Overview
11.8.3 Ekso Bionics Neurorehabilitation and Assistive Device Introduction
11.8.4 Ekso Bionics Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.8.5 Ekso Bionics Recent Development
11.9 Alter G
11.9.1 Alter G Company Detail
11.9.2 Alter G Business Overview
11.9.3 Alter G Neurorehabilitation and Assistive Device Introduction
11.9.4 Alter G Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.9.5 Alter G Recent Development
11.10 MagVenture
11.10.1 MagVenture Company Detail
11.10.2 MagVenture Business Overview
11.10.3 MagVenture Neurorehabilitation and Assistive Device Introduction
11.10.4 MagVenture Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.10.5 MagVenture Recent Development
11.11 Tyromotion
11.11.1 Tyromotion Company Detail
11.11.2 Tyromotion Business Overview
11.11.3 Tyromotion Neurorehabilitation and Assistive Device Introduction
11.11.4 Tyromotion Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.11.5 Tyromotion Recent Development
11.12 Soterix Medical
11.12.1 Soterix Medical Company Detail
11.12.2 Soterix Medical Business Overview
11.12.3 Soterix Medical Neurorehabilitation and Assistive Device Introduction
11.12.4 Soterix Medical Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.12.5 Soterix Medical Recent Development
11.13 Neuroelectrics
11.13.1 Neuroelectrics Company Detail
11.13.2 Neuroelectrics Business Overview
11.13.3 Neuroelectrics Neurorehabilitation and Assistive Device Introduction
11.13.4 Neuroelectrics Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.13.5 Neuroelectrics Recent Development
11.14 Bionik Laboratories
11.14.1 Bionik Laboratories Company Detail
11.14.2 Bionik Laboratories Business Overview
11.14.3 Bionik Laboratories Neurorehabilitation and Assistive Device Introduction
11.14.4 Bionik Laboratories Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.14.5 Bionik Laboratories Recent Development
11.15 Helius Medical
11.15.1 Helius Medical Company Detail
11.15.2 Helius Medical Business Overview
11.15.3 Helius Medical Neurorehabilitation and Assistive Device Introduction
11.15.4 Helius Medical Revenue in Neurorehabilitation and Assistive Device Business (2019-2024)
11.15.5 Helius Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma
Neuronetics
Magstim
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.